Southeast Asia Dose Optimization of Tafenoquine

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(5 sites)

Cambodia

Mahidol Oxford Tropical Medicine Research Unit (MORU), Cambodia, Siem Reap

Laos

Lao Oxford Mahosot Hospital Wellcome Trust Research Unit (LOMWRU), Vientiane

Thailand

Mahidol Vivax Research Unit (MVRU), Bangkok

Shoklo Malaria Research Unit (SMRU), Bangkok

Vietnam

Oxford University Clinical Research Unit (OUCRU), Bình Phước